rs1060503688
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_001022.4(RPS19):c.382C>T(p.Gln128*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001022.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001022.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RPS19 | MANE Select | c.382C>T | p.Gln128* | stop_gained | Exon 5 of 6 | NP_001013.1 | B0ZBD0 | ||
| RPS19 | c.382C>T | p.Gln128* | stop_gained | Exon 5 of 6 | NP_001308412.1 | B0ZBD0 | |||
| RPS19 | c.382C>T | p.Gln128* | stop_gained | Exon 5 of 6 | NP_001308413.1 | B0ZBD0 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RPS19 | TSL:1 MANE Select | c.382C>T | p.Gln128* | stop_gained | Exon 5 of 6 | ENSP00000470972.1 | P39019 | ||
| RPS19 | TSL:3 | c.382C>T | p.Gln128* | stop_gained | Exon 5 of 6 | ENSP00000470004.1 | P39019 | ||
| RPS19 | TSL:2 | c.382C>T | p.Gln128* | stop_gained | Exon 5 of 6 | ENSP00000469228.2 | P39019 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.